Category:
Rare Disease Day 2022: The Evolving Impact of Genomics and Precision Health
![Rare Disease Day 2022 with a ribbon and a map of the world](https://blogs.cdc.gov/genomics/wp-content/uploads/sites/20/2022/02/2022-02_rare.jpg)
In celebration of Rare Disease Day 2022, we reprint excerpts of four previous blogs. Rare Diseases, Genomics and Public Health: An Expanding Intersection (February 17, 2016) Rare Disease Day is celebrated on the last day of February each year. On that day, millions of patients and their families around the world share their stories in order Read More >
Posted on byUsing Pharmacogenetics to Enhance Tuberculosis (TB) Treatment
![a person pointing at different icons with tuberculosis in the background](https://blogs.cdc.gov/genomics/wp-content/uploads/sites/20/2022/02/2022-02_pharm_tb.jpg)
Through a funding opportunity from CDC’s Office of Genomics and Precision Public Health in collaboration with the CDC Office of Advanced Molecular Detection, CDC’s Division of Tuberculosis Elimination will conduct a 2-year project to assess relationships between pharmacogenetics (PG), TB drug exposure, relevant treatment outcomes, and safety. Researchers will use information collected in an international phase Read More >
Posted on byPrecision Public Health in Action: New CDC Pilot Projects Integrate Human Genomics into Public Health Surveillance and Applied Research
![a magnifying glass looking at a globe with DNA](https://blogs.cdc.gov/genomics/wp-content/uploads/sites/20/2022/02/2022-02_precision_public_health3.jpg)
In collaboration with the CDC Office of Advanced Molecular Detection, we recently launched a new, five-year initiative to strengthen public health capacity by introducing elements of human genomics into both public health surveillance and applied research. We report here on the successful launch of one of the initiative’s components. The Office of Genomics and Precision Public Read More >
Posted on by